Trial Profile
A long term follow-up study of Adalimumab in patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2016 New trial record